Cancer Overcoming drug resistance in cancer
Cancer patients frequently develop drug resistance. Martz et al. devised a method of identifying pathways causing resistance in cancer cells and found that Notch signaling – [Read More]
According to the American Cancer Society, cancer screening increases the chance of detecting certain cancers early, when they might be easier to treat. More good news from the National Cancer Institute shows that cancer survival rates are at an all-time high and cancer-related deaths are declining. Experts are attributing the improved outcomes to treatment advances, prevention awareness efforts — and screenings. Fortunately, today’s imagi ng technology provides an important tool in the fight…
When should immunotherapy be considered in patients with NSCLC and actionable driver mutations?Annals of Oncology
Roche today announced that results from a number of studies across its comprehensive oncology portfolio, covering a broad range of cancers including bladder, lung and breast will be presented at the European Society for Medical Oncology (ESMO) 2019 Congress, taking place from 27 September - 1 October in Barcelona, Spain.
This article describes the comprehensive overview of the current scenario of drug repurposing for the breast cancer treatment. The strategies as well as several examples of repurposed drugs are provided. The challenges associated with drug repurposing are discussed.
1. The breast is the most heavily guarded and protected part of a woman ’s body. This means there is good reason to worry less. Did you know that a mammogram is one of only two imaging tests (the other being a low-dose lung cancer screening for former or current heavy smokers) paid for by insurance companies in the U.S. for asymptomatic patients without any risk facto rs? It is the only part of a woman’s body which gets scrutinized every year. Finding breast cancer early (stage 1: less than…